Weight loss injection compared to a standard treatment
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new injection called bofanglutide to see if it helps people with overweight or obesity lose more weight than a standard treatment. It is for adults who have not been able to lose weight with diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is 30 or higher, or 27 to 30 with a weight-related health issue like high blood pressure or diabetes risk.
- You have been trying to lose weight with diet and exercise for at least 3 months, with your weight staying about the same.
- You are not currently taking any weight-loss medications or other drugs that affect weight.
- You have not had weight-loss surgery and do not plan to during the study.
- You are willing to keep a stable diet and exercise routine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
This trial tests a new way to deliver semaglutide through a strip placed on the tongue for weight loss in adults with obesity. It may help you lose weight without a needle.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.